Matches in Wikidata for { <http://www.wikidata.org/entity/Q37414394> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- Q37414394 description "article científic" @default.
- Q37414394 description "article scientifique" @default.
- Q37414394 description "articolo scientifico" @default.
- Q37414394 description "artigo científico" @default.
- Q37414394 description "artículu científicu espublizáu en 2016" @default.
- Q37414394 description "bilimsel makale" @default.
- Q37414394 description "scientific article published on 15 October 2016" @default.
- Q37414394 description "vedecký článok" @default.
- Q37414394 description "vetenskaplig artikel" @default.
- Q37414394 description "videnskabelig artikel" @default.
- Q37414394 description "vědecký článek" @default.
- Q37414394 description "wetenschappelijk artikel" @default.
- Q37414394 description "wissenschaftlicher Artikel" @default.
- Q37414394 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q37414394 description "научни чланак" @default.
- Q37414394 description "գիտական հոդված հրատարակված 2016 թվականի հոկտեմբերի 15-ին" @default.
- Q37414394 description "مقالة علمية نشرت في 15 أكتوبر 2016" @default.
- Q37414394 name "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 name "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 name "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 type Item @default.
- Q37414394 label "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 label "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 label "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 prefLabel "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 prefLabel "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 prefLabel "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 P1433 Q37414394-4F95459B-2AA5-45D0-B7DB-99AA08926348 @default.
- Q37414394 P1476 Q37414394-79C84857-93FE-42F4-9C4E-FAFE33A70A8F @default.
- Q37414394 P2093 Q37414394-31BE0B9D-0504-4E36-8169-88BC916FEEFF @default.
- Q37414394 P2093 Q37414394-C83B5FFF-C365-48CB-BF99-CF20AB7325AD @default.
- Q37414394 P2093 Q37414394-CFA550EE-83A4-4716-AD63-9BD8AC54B83B @default.
- Q37414394 P2093 Q37414394-DD9CFCB3-7EE2-4179-9B2D-8001DB3421AF @default.
- Q37414394 P2093 Q37414394-F61FEF14-153D-4898-87FC-4855EBF9429C @default.
- Q37414394 P2860 Q37414394-0BECD58F-6985-43E6-A196-4295206F7BEB @default.
- Q37414394 P2860 Q37414394-2391319A-F483-4084-808F-998D95AC2DD8 @default.
- Q37414394 P2860 Q37414394-268A2443-687C-4104-9CFC-EF6A37741A26 @default.
- Q37414394 P2860 Q37414394-4864D24E-2044-442B-84FC-E256A2055E25 @default.
- Q37414394 P2860 Q37414394-497C6C27-6117-4633-A505-55F457329E63 @default.
- Q37414394 P2860 Q37414394-7D515B9D-F75D-42CC-8476-4B1FF5D72C76 @default.
- Q37414394 P2860 Q37414394-8F7E99EE-0BAB-4DBA-9EAF-1791FDDD02DB @default.
- Q37414394 P2860 Q37414394-92731B23-4622-4AEE-8C58-68480B6E6E09 @default.
- Q37414394 P2860 Q37414394-B8CAA5C1-2D8F-41D0-A11B-19BD0603FBDE @default.
- Q37414394 P2860 Q37414394-BDF3741F-E9B9-4B91-8EAB-B4B1B6BF1518 @default.
- Q37414394 P2860 Q37414394-DBC8C708-A2B3-477F-BEE3-A77202D206AB @default.
- Q37414394 P2860 Q37414394-E3EACFCC-9F92-4737-BF58-22389E0EAF26 @default.
- Q37414394 P304 Q37414394-625BD276-61FD-40EE-AB9C-EAE23FFDBA8F @default.
- Q37414394 P31 Q37414394-6AE4F5C1-2AFE-4022-8E11-D87E1FCC67CB @default.
- Q37414394 P31 Q37414394-91841063-2fcc-46b9-9253-0a8adfa5aa8f @default.
- Q37414394 P356 Q37414394-A10F5EA8-F57D-4D7C-8A75-17E43592E774 @default.
- Q37414394 P433 Q37414394-2E3CEC5E-CFEE-4D70-8933-73D90BDB89A8 @default.
- Q37414394 P478 Q37414394-5B288E33-F885-4790-A58F-A459D596C582 @default.
- Q37414394 P577 Q37414394-48841522-4516-4D68-A2A3-B530D6313231 @default.
- Q37414394 P698 Q37414394-5B05DCD0-6530-43E0-903F-7B1DB546C19B @default.
- Q37414394 P921 Q37414394-924EAE93-09E2-4374-A7E4-AC94DC97EF1D @default.
- Q37414394 P921 Q37414394-E662D76B-094D-45C4-B7D4-626821B867EF @default.
- Q37414394 P932 Q37414394-910612DD-F24E-4A53-BD96-37DDCB210AF0 @default.
- Q37414394 P356 INTERNALMEDICINE.55.6470 @default.
- Q37414394 P698 27746443 @default.
- Q37414394 P1433 Q6047666 @default.
- Q37414394 P1476 "The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma" @default.
- Q37414394 P2093 "Naoko Sato" @default.
- Q37414394 P2093 "Shigeo Hashimoto" @default.
- Q37414394 P2093 "Takashi Kuroha" @default.
- Q37414394 P2093 "Tatsuo Furukawa" @default.
- Q37414394 P2093 "Toshio Yano" @default.
- Q37414394 P2860 Q27002668 @default.
- Q37414394 P2860 Q27005966 @default.
- Q37414394 P2860 Q33412804 @default.
- Q37414394 P2860 Q36258698 @default.
- Q37414394 P2860 Q36878944 @default.
- Q37414394 P2860 Q37917337 @default.
- Q37414394 P2860 Q42272171 @default.
- Q37414394 P2860 Q42914716 @default.
- Q37414394 P2860 Q44918517 @default.
- Q37414394 P2860 Q45310359 @default.
- Q37414394 P2860 Q56453538 @default.
- Q37414394 P2860 Q56981141 @default.
- Q37414394 P304 "3025-3028" @default.
- Q37414394 P31 Q13442814 @default.
- Q37414394 P31 Q2782326 @default.
- Q37414394 P356 "10.2169/INTERNALMEDICINE.55.6470" @default.
- Q37414394 P433 "20" @default.
- Q37414394 P478 "55" @default.
- Q37414394 P577 "2016-10-15T00:00:00Z" @default.
- Q37414394 P698 "27746443" @default.
- Q37414394 P921 Q203174 @default.
- Q37414394 P921 Q422252 @default.
- Q37414394 P932 "5109573" @default.